Pre-Diabetes and the Risk for Cardiovascular Disease. A Systematic Review of the Evidence

Journal of the American College of Cardiology

Volumn 55, Issue 13, 2010, Pages 1310-1317

  Ford, Earl S ^a   Zhao, Guixiang ^a   Li, Chaoyang ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

cardiovascular diseases; coronary heart disease; hyperglycemia; meta analysis; prediabetic state; review

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FIXED EFFECTS SUMMARY ESTIMATE; HUMAN; HYPERGLYCEMIA; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MEDLINE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL PARAMETERS; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; PREDIABETIC STATE; RISK ASSESSMENT; RISK FACTORS;

EID: 77949553029     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.060     Document Type: Article

References (54)

1. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
2. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?. A meta-analysis of prospective studies. Arch Intern Med 164 (2004) 2147-2155
3. Danaei G., Lawes C.M., Vander H.S., Murray C.J., and Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368 (2006) 1651-1659
4. The DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
5. Lee W.L., Cheung A.M., Cape D., and Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23 (2000) 962-968
6. Kanaya A.M., Grady D., and Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162 (2002) 1737-1745
7. Huxley R., Woodward M., Barzi F., Wong J.W., Pan W.H., and Patel A. Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region?. J Womens Health (Larchmt) 14 (2005) 820-828
8. Huxley R., Barzi F., and Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332 (2006) 73-78
9. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
11. World Health Organization. Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series 727 (1985), World Health Organization, Geneva
12. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2 (1999), World Health Organization, Geneva
13. Cowie C.C., Rust K.F., Ford E.S., et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32 (2009) 287-294
14. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
15. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9 (1987) 1-30
16. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull 47 (1999) 15-17
17. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
18. Barzilay J.I., Spiekerman C.F., Wahl P.W., et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 354 (1999) 622-625
19. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
20. Saydah S.H., Loria C.M., Eberhardt M.S., and Brancati F.L. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 24 (2001) 447-453
21. Saydah S.H., Miret M., Sung J., Varas C., Gause D., and Brancati F.L. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24 (2001) 1397-1402
22. Henry P., Thomas F., Benetos A., and Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 40 (2002) 458-463
23. The DECODE Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
24. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26 (2003) 1251-1257
25. Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47 (2004) 385-394
26. Nakanishi N., Takatorige T., Fukuda H., et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 64 (2004) 59-70
27. Tai E.S., Goh S.Y., Lee J.J., et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27 (2004) 1728-1734
28. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., and Stern M.P. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
29. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
30. Wild S.H., Smith F.B., Lee A.J., and Fowkes F.G. Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort. Diabet Med 22 (2005) 490-496
31. Thrainsdottir I.S., Aspelund T., Hardarson T., et al. Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study. Eur J Cardiovasc Prev Rehabil 12 (2005) 465-471
32. Palmieri L., Donfrancesco C., Giampaoli S., et al. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil 13 (2006) 562-570
33. McNeill A.M., Katz R., Girman C.J., et al. Metabolic syndrome and cardiovascular disease in older people: the cardiovascular health study. J Am Geriatr Soc 54 (2006) 1317-1324
34. Rijkelijkhuizen J.M., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D., and Dekker J.M. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 30 (2007) 332-336
35. Liu J., Grundy S.M., Wang W., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J 153 (2007) 552-558
36. Nilsson P.M., Engstrom G., and Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions. Diabet Med 24 (2007) 464-472
37. Wang J., Ruotsalainen S., Moilanen L., Lepisto P., Laakso M., and Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28 (2007) 857-864
38. Wang J.J., Li H.B., Kinnunen L., et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?. Atherosclerosis 192 (2007) 161-168
39. Barr E.L., Zimmet P.Z., Welborn T.A., et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116 (2007) 151-157
40. Levitzky Y.S., Pencina M.J., D'Agostino R.B., et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 51 (2008) 264-270
41. Wannamethee S.G. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study. Int J Obes (Lond) 32 Suppl 2 (2008) S25-S29
42. Chien K.L., Hsu H.C., Su T.C., Chen M.F., Lee Y.T., and Hu F.B. Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study. Am Heart J 156 (2008) 996-1002
43. Lu W., Resnick H.E., Jain A.K., et al. Effects of isolated post-challenge hyperglycemia on mortality in American Indians: the Strong Heart Study. Ann Epidemiol 13 (2003) 182-188
44. Pankow J.S., Kwan D.K., Duncan B.B., et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care 30 (2007) 325-331
45. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48 (1999) 937-942
46. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., and Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1 (1980) 1373-1376
47. Pyorala K., Laakso M., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3 (1987) 463-524
48. Jarrett R.J., McCartney P., and Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22 (1982) 79-84
49. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., and Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 287 (1983) 867-870
50. Eschwege E., Richard J.L., Thibult N., et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl 15 (1985) 41-46
51. Fujishima M., Kiyohara Y., Kato I., et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 45 Suppl 3 (1996) S14-S16
52. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
53. de Vegt F., Dekker J.M., Ruhe H.G., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931
54. Qiao Q., Jousilahti P., Eriksson J., and Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26 (2003) 2910-2914